{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:19:56Z","timestamp":1707524396063},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,20]]},"DOI":"10.7759\/cureus.18121","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T14:04:37Z","timestamp":1632146677000},"source":"Crossref","is-referenced-by-count":0,"title":["Acute Psychosis and COVID-19 Infection: Psychiatric Symptoms in Hospitalized Patients"],"prefix":"10.7759","author":[{"given":"Sana Elham","family":"Kazi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selina","family":"Akhter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Periasamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzana","family":"Faruki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7326\/M20-6976","article-title":"The proportion of SARS-CoV-2 infections that are asymptomatic: a systematic review","volume":"174","author":"Oran DP","year":"2021","unstructured":"Oran DP, Topol EJ. The proportion of SARS-CoV-2 infections that are asymptomatic: a systematic review. Ann Intern Med. 2021, 174:655-62. 10.7326\/M20-6976","journal-title":"Ann Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234765","article-title":"The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): a systematic review and meta-analysis of 148 studies from 9 countries","volume":"15","author":"Grant MC","year":"2020","unstructured":"Grant MC, Geoghegan L, Arbyn M, Mohammed Z, McGuinness L, Clarke EL, Wade RG. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): a systematic review and meta-analysis of 148 studies from 9 countries. PLoS One. 2020, 15:10.1371\/journal.pone.0234765","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-020-09944-5","article-title":"The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections","volume":"15","author":"Machhi J","year":"2020","unstructured":"Machhi J, Herskovitz J, Senan AM, et al.. The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. J Neuroimmune Pharmacol. 2020, 15:359-86. 10.1007\/s11481-020-09944-5","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-021-00954-4","article-title":"Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients","volume":"27","author":"Hellmuth J","year":"2021","unstructured":"Hellmuth J, Barnett TA, Asken BM, et al.. Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. J Neurovirol. 2021, 27:191-5. 10.1007\/s13365-021-00954-4","journal-title":"J Neurovirol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/09602011.2020.1808483","article-title":"Neuropsychological consequences of COVID-19","volume":"30","author":"Wilson BA","year":"2020","unstructured":"Wilson BA, Betteridge S, Fish J. Neuropsychological consequences of COVID-19. Neuropsychol Rehabil. 2020, 30:1625-8. 10.1080\/09602011.2020.1808483","journal-title":"Neuropsychol Rehabil"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000713","article-title":"A systematic review of neuropsychological and psychiatric sequalae of COVID-19: implications for treatment","volume":"34","author":"Vanderlind WM","year":"2021","unstructured":"Vanderlind WM, Rabinovitz BB, Miao IY, et al.. A systematic review of neuropsychological and psychiatric sequalae of COVID-19: implications for treatment. Curr Opin Psychiatry. 2021, 34:420-33. 10.1097\/YCO.0000000000000713","journal-title":"Curr Opin Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(20)30287-X","article-title":"Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study","volume":"7","author":"Varatharaj A","year":"2020","unstructured":"Varatharaj A, Thomas N, Ellul MA, et al.. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020, 7:875-82. 10.1016\/S2215-0366(20)30287-X","journal-title":"Lancet Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(20)30462-4","article-title":"Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62\u2008354 COVID-19 cases in the USA","volume":"8","author":"Taquet M","year":"2021","unstructured":"Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62\u2008354 COVID-19 cases in the USA. Lancet Psychiatry. 2021, 8:130-40. 10.1016\/S2215-0366(20)30462-4","journal-title":"Lancet Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2020.157","article-title":"Implications of the COVID-19 pandemic for patients with schizophrenia spectrum disorders: narrative review","volume":"7","author":"Zhand N","year":"2021","unstructured":"Zhand N, Joober R. Implications of the COVID-19 pandemic for patients with schizophrenia spectrum disorders: narrative review. BJPsych Open. 2021, 7:35. 10.1192\/bjo.2020.157","journal-title":"BJPsych Open"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2020.113254","article-title":"Psychotic symptoms in COVID-19 patients. A retrospective descriptive study","volume":"291","author":"Parra A","year":"2020","unstructured":"Parra A, Juanes A, Losada CP, et al.. Psychotic symptoms in COVID-19 patients. A retrospective descriptive study. Psychiatry Res. 2020, 291:10.1016\/j.psychres.2020.113254","journal-title":"Psychiatry Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2020.04.027","article-title":"Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms","volume":"87","author":"Troyer EA","year":"2020","unstructured":"Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun. 2020, 87:34-9. 10.1016\/j.bbi.2020.04.027","journal-title":"Brain Behav Immun"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2021.07.018","article-title":"Psychiatric and neuropsychiatric sequelae of COVID-19 - a systematic review","volume":"97","author":"Schou TM","year":"2021","unstructured":"Schou TM, Joca S, Wegener G, Bay-Richter C. Psychiatric and neuropsychiatric sequelae of COVID-19 - a systematic review. Brain Behav Immun. 2021, 97:328-48. 10.1016\/j.bbi.2021.07.018","journal-title":"Brain Behav Immun"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30308-2","article-title":"Neuropathology of patients with COVID-19 in Germany: a post-mortem case series","volume":"19","author":"Matschke J","year":"2020","unstructured":"Matschke J, L\u00fctgehetmann M, Hagel C, et al.. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020, 19:919-29. 10.1016\/S1474-4422(20)30308-2","journal-title":"Lancet Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1017\/neu.2021.13","article-title":"Inflammatory neuropsychiatric disorders and COVID-19 neuroinflammation","volume":"33","author":"Tang SW","year":"2021","unstructured":"Tang SW, Helmeste D, Leonard B. Inflammatory neuropsychiatric disorders and COVID-19 neuroinflammation. Acta Neuropsychiatr. 2021, 33:165-77. 10.1017\/neu.2021.13","journal-title":"Acta Neuropsychiatr"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2021.0500","article-title":"How COVID-19 affects the brain","volume":"78","author":"Boldrini M","year":"2021","unstructured":"Boldrini M, Canoll PD, Klein RS. How COVID-19 affects the brain. JAMA Psychiatry. 2021, 78:682-3. 10.1001\/jamapsychiatry.2021.0500","journal-title":"JAMA Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/PRA.0000000000000105","article-title":"Beyond urinary tract infections (UTIs) and delirium: a systematic review of UTIs and neuropsychiatric disorders","volume":"21","author":"Chae JH","year":"2015","unstructured":"Chae JH, Miller BJ. Beyond urinary tract infections (UTIs) and delirium: a systematic review of UTIs and neuropsychiatric disorders. J Psychiatr Pract. 2015, 21:402-11. 10.1097\/PRA.0000000000000105","journal-title":"J Psychiatr Pract"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.17-0042","article-title":"Serious neurological adverse events after ivermectin-do they occur beyond the indication of onchocerciasis?","volume":"98","author":"Chandler RE","year":"2018","unstructured":"Chandler RE. Serious neurological adverse events after ivermectin-do they occur beyond the indication of onchocerciasis?. Am J Trop Med Hyg. 2018, 98:382-8. 10.4269\/ajtmh.17-0042","journal-title":"Am J Trop Med Hyg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2011.01.006","article-title":"Psychosis, ivermectin toxicity, and \"Morgellons disease\"","volume":"52","author":"DeBonis K","year":"2011","unstructured":"DeBonis K, Pierre JM. Psychosis, ivermectin toxicity, and \"Morgellons disease\". Psychosomatics. 2011, 52:295-6. 10.1016\/j.psym.2011.01.006","journal-title":"Psychosomatics"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2020.06.001","article-title":"COVID-19 treatment-induced neuropsychiatric adverse effects","volume":"67","author":"Garc\u00eda CA","year":"2020","unstructured":"Garc\u00eda CA, S\u00e1nchez EB, Huerta DH, G\u00f3mez-Arnau J. COVID-19 treatment-induced neuropsychiatric adverse effects. Gen Hosp Psychiatry. 2020, 67:163-4. 10.1016\/j.genhosppsych.2020.06.001","journal-title":"Gen Hosp Psychiatry"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/070674370204700622","article-title":"Delirium associated with azithromycin administration. [Article in French]","volume":"47","author":"Sirois F","year":"2002","unstructured":"Sirois F. Delirium associated with azithromycin administration. [Article in French]. Can J Psychiatry. 2002, 47:585-6. 10.1177\/070674370204700622","journal-title":"Can J Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-010-0900-8","article-title":"Neuropsychiatric manifestations associated with azithromycin in two brothers","volume":"66","author":"Schiff E","year":"2010","unstructured":"Schiff E, May K, Goldstein LH. Neuropsychiatric manifestations associated with azithromycin in two brothers. Eur J Clin Pharmacol. 2010, 66:1273-5. 10.1007\/s00228-010-0900-8","journal-title":"Eur J Clin Pharmacol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2011.12.007","article-title":"The neuropsychiatric complications of glucocorticoid use: steroid psychosis revisited","volume":"53","author":"Dubovsky AN","year":"2012","unstructured":"Dubovsky AN, Arvikar S, Stern TA, Axelrod L. The neuropsychiatric complications of glucocorticoid use: steroid psychosis revisited. Psychosomatics. 2012, 53:103-15. 10.1016\/j.psym.2011.12.007","journal-title":"Psychosomatics"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2020.06.022","article-title":"Psychiatric aspects of chloroquine and hydroxychloroquine treatment in the wake of coronavirus disease-2019: psychopharmacological interactions and neuropsychiatric sequelae","volume":"61","author":"Hamm BS","year":"2020","unstructured":"Hamm BS, Rosenthal LJ. Psychiatric aspects of chloroquine and hydroxychloroquine treatment in the wake of coronavirus disease-2019: psychopharmacological interactions and neuropsychiatric sequelae. Psychosomatics. 2020, 61:597-606. 10.1016\/j.psym.2020.06.022","journal-title":"Psychosomatics"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2020.05.032","article-title":"Chloroquine-induced first-episode psychosis in a patient self-medicated for COVID-19","volume":"89","author":"Ambar Akkaoui M","year":"2021","unstructured":"Ambar Akkaoui M, Lejoyeux M, Geoffroy PA. Chloroquine-induced first-episode psychosis in a patient self-medicated for COVID-19. Biol Psychiatry. 2021, 89:9. 10.1016\/j.biopsych.2020.05.032","journal-title":"Biol Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/70524-acute-psychosis-and-covid-19-infection-psychiatric-symptoms-in-hospitalized-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:29:56Z","timestamp":1707506996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/70524-acute-psychosis-and-covid-19-infection-psychiatric-symptoms-in-hospitalized-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,20]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.18121","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,20]]}}}